Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Aug 2026, 00:11
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AEGISVOPAK's quarterly gross margin accelerated to 98.74%, up from 53.03%.
The company's marginal operating leverage also accelerated to , up from 32.13%. Additionally, revenue growth year-over-year accelerated to , up from 30.4%. On the trading front, the stock's close price accelerated to , up from 266.6 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 98.74 % | 53.03 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 53.03 % | 32.13 | ▲ |
| REVENUE_GROWTH_YOY | 42.5 % | 30.4 | ▲ |
| PRICE_CHANGE_PERCENT | 3.638 % | — | - |
| DAILY_VOLUME | 8,49,977 shares | 18,21,176 | ▼ |
| CLOSE_PRICE | 276.3 INR | 266.6 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.67 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 2 | ▼ |
| TARGET_PRICE_PREMIUM | 18.35 % | — | - |